Freyman will become the fourth new Director joining the Allergan Board in 16 months as we continue to recruit highly-experienced and qualified members to bring a diversity of perspectives and strengthen the Board with additional industry, scientific and financial experience." Allergan also announced that director Patrick O'Sullivan will retire from the Allergan Board of Directors in July. Mr. O'Sullivan joined the Board of Directors in October 2013 following the Company's acquisition of Warner Chilcott plc, having served as a member of the Warner Chilcott Board from 2009. Following the retirement of Mr. O'Sullivan and the addition of Mr. Freyman, Allergan's Board of Directors will continue to have 12 members of which 10 are independent. " Tom Freyman is an accomplished healthcare industry executive with a strong track record of optimizing capital allocation and creating shareholder value," said Brent L. Saunders, Chairman and Chief Executive Officer at Allergan.